Skip to content

ANGOPHAR

Active
Public limited companyfounded 1996active for 29 yearsSchuitenkaai 2, 1000 Brussel, BelgiumKBO/BCE: BE 0459.316.972

From the official registers: KBO 28 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

ANGOPHAR has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €681,310 and a net result of €136,623. Equity has been growing by about 4.4% per year since 2018. Its solvency ranks better than 67% of 9,537 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Financials · financial year 2024, abbreviated format

2025 annual accounts not yet filed, deadline passed on 31 July 2026 The financial year closed on 31 December 2025. The accounts are due at the latest 7 months after the close (Companies Code art. 3:10). Source: NBB filings, as of 1 November 2026.

Latest annual accounts filed

Annual accounts 2024

Download PDF
Financial year ended
31-12-2024
Filed on
29-08-2025
Format
abbreviated format
Reference
2025-00484629
Turnover
≈ €1.0m
Estimated: probably between €810,000 and €1.7m
Total assets
€1.3m▲ 6.6%
2023 · €1.2m
Net result
€136,623▲ 39.0%
2023 · €98,271
Working capital
€591,572▲ 6.2%
2023 · €556,786
Trend over the years

2020 to 2024, 5 financial years 2018 to 2024, 7 financial years

The operating result for 2024 is 13% higher than in 2023 and the highest since 2020. It is a recovery after the fall in 2023.

Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.

Operating result€0.1m 2024 Net result€0.1m 2024

Use the arrow keys on the chart for the figures per year.

The sector band is the middle half of the companies in Retail trade (NACE 47). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio, return on assets (ROA) and staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line2018201920202021202220232024
Operating result€0.02m-€0.04m▲ 50.6%€0.03m▼ 24.8%€0.07m▲ 181%€0.1m▲ 54.5%€0.1m▼ 4.4%€0.1m▲ 12.6%
Net result€0.01m-€0.02m▲ 8.3%€0.02mwithin the sector's middle half▲ 4.1%€0.06mwithin the sector's middle half▲ 293%€0.1mwithin the sector's middle half▲ 66.1%€0.1mwithin the sector's middle half▼ 5.6%€0.1mabove the sector's middle half▲ 39.0%
Equity€0.5m-€0.5m▲ 1.9%€0.6mwithin the sector's middle half▲ 2.9%€0.6mwithin the sector's middle half▲ 11.2%€0.6mwithin the sector's middle half▲ 2.3%€0.6mwithin the sector's middle half▲ 1.3%€0.7mwithin the sector's middle half▲ 5.7%
Total assets€0.8m-€0.8m▲ 3.6%€1.3mwithin the sector's middle half▲ 52.3%€1.2mwithin the sector's middle half▼ 4.4%€1.3mwithin the sector's middle half▲ 4.4%€1.2mwithin the sector's middle half▼ 7.1%€1.3mwithin the sector's middle half▲ 6.6%
Debt€0.3m-€0.3m▲ 6.7%€0.7m▲ 144%€0.6m▼ 16.6%€0.6m▲ 6.6%€0.5m▼ 15.6%€0.6m▲ 7.7%
Working capital€0.5m-€0.6m▲ 3.2%€0.5mabove the sector's middle half▼ 8.8%€0.6mabove the sector's middle half▲ 10.2%€0.6mabove the sector's middle half▼ 1.8%€0.6mabove the sector's middle half▲ 0.4%€0.6mabove the sector's middle half▲ 6.2%
Solvency66.0%-65.0%▼ 1.0pp43.9%within the sector's middle half▼ 21.1pp51.1%within the sector's middle half▲ 7.2pp50.1%within the sector's middle half▼ 1.0pp54.6%within the sector's middle half▲ 4.5pp54.1%within the sector's middle half▼ 0.5pp
Current ratio4.39-4.15▼ 0.242.83above the sector's middle half▼ 1.313.40above the sector's middle half▲ 0.562.61within the sector's middle half▼ 0.792.84above the sector's middle half▲ 0.232.55within the sector's middle half▼ 0.29
Return on assets (ROA)1.8%-1.8%▲ 0.1pp1.3%within the sector's middle half▼ 0.6pp5.1%within the sector's middle half▲ 3.9pp8.2%within the sector's middle half▲ 3.0pp8.3%within the sector's middle half▲ 0.1pp10.9%within the sector's middle half▲ 2.5pp
Staff (FTE)1.7-1.1▼ 35.3%1.3below the sector's middle half▲ 18.2%1.8within the sector's middle half▲ 38.5%1.5below the sector's middle half▼ 16.7%1.6within the sector's middle half▲ 6.7%1.7within the sector's middle half▲ 6.3%
above within below The sector band is the middle half of the companies in Retail trade (NACE 47). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.3m
Fixed assets €286,035 ▼ 11.1%
Current assets €972,562 ▲ 13.2%
Equity and liabilities €1.3m
Equity €681,310 ▲ 5.7%
Debt €577,287 ▲ 7.7%
Debt's share of the balance-sheet total rises from 45.4% to 45.9%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€167,920▲
2023 · €163,335
Cash flow
€180,897▲
2023 · €151,751
Quick ratio
1.96▼
2023 · 2.18
Debt to equity
0.85▲
2023 · 0.83
ROE
20.1%▲
2023 · 15.2%
Interest coverage
14.12▼
2023 · 20.69
Debt ≤ 1 year
€380,990▲
2023 · €302,520
Debt > 1 year
€195,591▼
2023 · €233,551
Income taxes
€6,048▼
2023 · €6,654
Staff costs
€116,266▲
2023 · €90,299
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Companies with the same profile, two years later

Historical observation

In July 2024, 31,368 companies had the same profile as ANGOPHAR has now. Two years later, 0.5% had gone bankrupt and 93.5% were still going.

  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.5% went bankrupt
5.9% stopped otherwise
93.5% was still going

Another 0.1% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of ANGOPHAR itself: 0.3% within 12 months.

Test of the method

The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,368 companies, not a prediction for ANGOPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 59 lines

Source: Annual accounts 2024 (PDF), filed on 29-08-2025.

Balance sheet Code20232024
Assets
Total assets20/58€1.2m€1.3m▲
Fixed assets21/28€0.3m€0.3m▼
Tangible fixed assets22/27€0.3m€0.3m▼
Land and buildings22€0.001m€0.001m▼
Plant, machinery and equipment23€0.07m€0.05m▼
Furniture and vehicles24€0.001m€0.001m▼
Other tangible fixed assets26€0.3m€0.2m▼
Current assets29/58€0.9m€1.0m▲
Stocks and contracts in progress3€0.2m€0.2m▲
Stocks30/36€0.2m€0.2m▲
Amounts receivable within one year40/41€0.2m€0.2m▲
Trade receivables40€0.2m€0.2m▲
Other amounts receivable41€0.03m€0.003m▼
Current investments50/53€0.3m€0.3m▲
Cash at bank and in hand54/58€0.1m€0.2m▲
Deferred charges and accrued income490/1€0.01m€0.007m▼
Equity and liabilities
Total equity and liabilities10/49€1.2m€1.3m▲
Equity10/15€0.6m€0.7m▲
Contributions10/11€0.3m€0.3m=
Capital10€0.3m€0.3m=
Issued capital100€0.3m€0.3m=
Reserves13€0.2m€0.2m=
Non-distributable reserves130/1€0.03m€0.03m=
Legal reserve130€0.03m€0.03m=
Tax-exempt reserves132€0.01m€0.01m=
Distributable reserves133€0.2m€0.2m=
Profit (loss) carried forward14€0.1m€0.1m▲
Amounts payable17/49€0.5m€0.6m▲
Amounts payable after more than one year17€0.2m€0.2m▼
Financial debts170/4€0.2m€0.2m▼
Amounts payable within one year42/48€0.3m€0.4m▲
Current portion of amounts payable after more than one year42€0.05m€0.04m▼
Trade debts44€0.1m€0.1m▲
Suppliers440/4€0.1m€0.1m▲
Taxes, remuneration and social security45€0.02m€0.03m▲
Taxes450/3€0.009m€0.01m▲
Remuneration and social security454/9€0.01m€0.02m▲
Other amounts payable47/48€0.1m€0.2m▲
Accrued charges and deferred income492/3€135€0.001m▲
Income statement Code20232024
Non-recurring operating income76A-€0.006m
Remuneration, social security and pensions62€0.09m€0.1m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.05m€0.04m▼
Other operating charges640/8€0.001m€0.002m▲
Gross operating margin9900€0.3m€0.3m▲
Operating profit (loss)9901€0.1m€0.1m▲
Financial income75/76B€0.003m€0.03m▲
Recurring financial income75€0.002m€0.03m▲
Non-recurring financial income76B€0.001m€0.002m▲
Financial charges65/66B€0.008m€0.01m▲
Recurring financial charges65€0.008m€0.01m▲
Profit (loss) for the period before taxes9903€0.1m€0.1m▲
Income taxes67/77€0.007m€0.006m▼
Profit (loss) for the period9904€0.1m€0.1m▲
Profit (loss) for the period to be appropriated9905€0.1m€0.1m▲
Appropriation of the result
Profit (loss) to be appropriated9906€0.2m€0.2m▲
Profit (loss) brought forward from the previous period14P€0.09m€0.1m▲
Profit to be distributed694/7€0.09m€0.1m▲
Directors or managers695€0.09m€0.1m▲
Social balance sheet
Average headcount (FTE)90871.61.7▲

The notes to these accounts have 10 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Line2018201920202021202220232024Change
Non-recurring operating income76A---€100€1,861-€5,762-
Remuneration, social security and pensions62---€102,746€90,247€90,299€116,266▲ 28.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€44,915€50,771€65,517€70,633€53,425€53,481€44,274▼ 17.2%
Other operating charges640/8---€2,332€1,631€1,495€1,707▲ 14.1%
Gross operating margin9900€176,074€164,394€170,967€250,144€260,274€255,130€285,892▲ 12.1%
Operating profit (loss)9901€23,348€35,171€26,460€74,433€114,970€109,854€123,646▲ 12.6%
Financial income75/76B---€1,538€1,645€2,966€30,915▲ 942%
Recurring financial income75€1,994€1,138€1,954€1,538€1,645€1,594€28,875▲ 18×
Non-recurring financial income76B-----€1,372€2,040▲ 48.7%
Financial charges65/66B---€13,265€11,586€7,895€11,890▲ 50.6%
Recurring financial charges65€5,683€12,342€12,460€13,265€11,586€7,895€11,890▲ 50.6%
Profit (loss) for the period before taxes9903€19,659€23,967€15,954€62,705€105,029€104,925€142,671▲ 36.0%
Income taxes67/77€5,505€8,644-€0€881€6,654€6,048▼ 9.1%
Profit (loss) for the period9904€14,155€15,323€15,954€62,705€104,148€98,271€136,623▲ 39.0%
Profit (loss) for the period to be appropriated9905€14,155€15,323€15,954€62,705€104,148€98,271€136,623▲ 39.0%
Line2018201920202021202220232024Change
Assets
Total assets20/58€0.8m€0.8m€1.3m€1.2m€1.3m€1.2m€1.3m▲ 6.6%
Fixed assets21/28€0.1m€0.1m€0.5m€0.4m€0.4m€0.3m€0.3m▼ 11.1%
Intangible fixed assets21€0.07m€0.04m€0.02m-----
Tangible fixed assets22/27€0.03m€0.05m€0.5m€0.4m€0.4m€0.3m€0.3m▼ 11.1%
Land and buildings22---€0.005m€0.002m€0.001m€0.001m▼ 38.3%
Plant, machinery and equipment23---€0.1m€0.08m€0.07m€0.05m▼ 18.2%
Furniture and vehicles24---€0.02m€0.01m€0.001m€0.001m▼ 57.8%
Other tangible fixed assets26---€0.3m€0.3m€0.3m€0.2m▼ 8.8%
Current assets29/58€0.7m€0.7m€0.8m€0.8m€0.9m€0.9m€1.0m▲ 13.2%
Stocks and contracts in progress3€0.1m€0.1m€0.1m€0.2m€0.2m€0.2m€0.2m▲ 12.1%
Stocks30/36---€0.2m€0.2m€0.2m€0.2m▲ 12.1%
Amounts receivable within one year40/41€0.3m€0.2m€0.3m€0.3m€0.4m€0.2m€0.2m▲ 5.5%
Trade receivables40---€0.2m€0.3m€0.2m€0.2m▲ 20.4%
Other amounts receivable41---€0.06m€0.1m€0.03m€0.003m▼ 90.8%
Current investments50/53€0.2m€0.2m€0.2m€0.2m€0.2m€0.3m€0.3m▲ 3.2%
Cash at bank and in hand54/58€0.1m€0.2m€0.1m€0.1m€0.1m€0.1m€0.2m▲ 48.9%
Deferred charges and accrued income490/1---€0.01m€0.009m€0.01m€0.007m▼ 34.0%
Equity and liabilities
Total equity and liabilities10/49€0.8m€0.8m€1.3m€1.2m€1.3m€1.2m€1.3m▲ 6.6%
Equity10/15€0.5m€0.5m€0.6m€0.6m€0.6m€0.6m€0.7m▲ 5.7%
Contributions10/11€0.3m€0.3m€0.3m€0.3m€0.3m€0.3m€0.3m=
Capital10---€0.3m€0.3m€0.3m€0.3m=
Issued capital100---€0.3m€0.3m€0.3m€0.3m=
Reserves13€0.2m€0.2m€0.2m€0.2m€0.2m€0.2m€0.2m=
Non-distributable reserves130/1---€0.03m€0.03m€0.03m€0.03m=
Legal reserve130---€0.03m€0.03m€0.03m€0.03m=
Tax-exempt reserves132---€0.01m€0.01m€0.01m€0.01m=
Distributable reserves133---€0.2m€0.2m€0.2m€0.2m=
Profit (loss) carried forward14-€0.01m€0.02m€0.08m€0.09m€0.1m€0.1m▲ 37.2%
Amounts payable17/49€0.3m€0.3m€0.7m€0.6m€0.6m€0.5m€0.6m▲ 7.7%
Amounts payable after more than one year17€0.1m€0.1m€0.4m€0.4m€0.3m€0.2m€0.2m▼ 16.3%
Financial debts170/4---€0.4m€0.3m€0.2m€0.2m▼ 16.3%
Amounts payable within one year42/48€0.2m€0.2m€0.3m€0.2m€0.3m€0.3m€0.4m▲ 25.9%
Current portion of amounts payable after more than one year42---€0.08m€0.08m€0.05m€0.04m▼ 24.3%
Trade debts44€0.1m€0.1m€0.2m€0.1m€0.1m€0.1m€0.1m▲ 29.4%
Suppliers440/4---€0.1m€0.1m€0.1m€0.1m▲ 29.4%
Taxes, remuneration and social security45---€0.02m€0.02m€0.02m€0.03m▲ 36.7%
Taxes450/3---€411€0.003m€0.009m€0.01m▲ 10.4%
Remuneration and social security454/9---€0.02m€0.01m€0.01m€0.02m▲ 54.6%
Other amounts payable47/48---€0.02m€0.1m€0.1m€0.2m▲ 43.3%
Accrued charges and deferred income492/3---€49€0.006m€135€0.001m▲ 423%
Line2018201920202021202220232024Change
Profit (loss) for the period9904€14,155€15,323€15,954€62,705€104,148€98,271€136,623▲ 39.0%
+ Depreciation and write-downs630€44,915€50,771€65,517€70,633€53,425€53,481€44,274▼ 17.2%
Operating cash flow (approximation)€59,070€66,094€81,471€133,338€157,574€151,751€180,897▲ 19.2%
Investment in fixed assets (approximation)--€44,305-€451,976-€6,490-€7,813-€2,652-€8,722▼ 229%
Change in cash-€82,373-€73,479€9,640-€9,852€41,239€71,809▲ 74.1%

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 28 filings with the National Bank
Financial year Type Filed Reference Document
31-12-2024 abbreviated format 29-08-2025 2025-00484629 PDF
31-12-2023 abbreviated format 27-08-2024 2024-00430117 PDF
31-12-2022 abbreviated format 31-08-2023 2023-00441988 PDF
31-12-2021 abbreviated format 31-08-2022 2022-20418659 PDF
31-12-2020 abbreviated format 19-08-2021 2021-50300090 PDF
31-12-2019 abbreviated format 28-08-2020 2020-47500320 PDF
31-12-2018 abbreviated format 25-06-2019 2019-23300173 PDF
31-12-2017 abbreviated format 29-05-2018 2018-14600105 PDF
31-12-2016 abbreviated format 13-07-2017 2017-31600162 PDF
31-12-2015 abbreviated format 30-09-2016 2016-63000372 PDF

Show all 28 filings

Comparable companies

These companies have the same main activity as ANGOPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.4m, founded between 1992 and 2002.

CompanyFoundedTotal assetsEquityGross marginTurnoverNet resultFTEFinancial year
ANGOPHAR Brussel1996€1.3m€0.7m€0.3m-€0.1m1.72024
APOTHEEK DE PRETER A. Sint-Niklaas2001€1.3m€0.3m€0.3m-€0.02m1.92025
PHARMACIE VRANCKEN Faimes2002€1.3m€0.5m€0.3m-€0.05m1.72025
PHARMACIE LECOMTE Bernissart1993€1.4m€1.2m€0.3m-€0.08m22025
apotheek de plaats Menen1992€1.1m€0.2m€0.3m-€0.1m1.82025
APOTHEEK GEERT VANDERHEYDEN Maaseik1996€1.1m€0.2m€0.3m-€0.2m1.72025
PHARMACIE MARCOTTY Neupré1998€1.0m€0.6m€0.3m€0€0.09m1.92025

They were chosen from the 3,936 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity

Public contracts

2 awards · 2023
Marché public de fournitures à bordereau de prix et en 2 lots ayant pour but la fourniture, pendant 48 mois, de médicaments à usage humain et de produits parapharmaceutiques: Marché public de fournitures à bordereau de prix ayant pour but la fourniture, pendant 48 mois, de médicaments à usage humain
buyer: Ville de Bruxelles, département Achats & FacilitiesMedical equipment and pharmaceuticalsawarded 16-05-20231 tenderTED 373827-2023
Marché public de fournitures à bordereau de prix et en 2 lots ayant pour but la fourniture, pendant 48 mois, de médicaments à usage humain et de produits parapharmaceutiques: Marché public de fournitures à bordereau de prix ayant pour but la fourniture, pendant 48 mois, de produits parapharmaceutiques
buyer: Ville de Bruxelles, département Achats & FacilitiesMedical equipment and pharmaceuticalsawarded 16-05-20231 tenderTED 373827-2023

Source: TED (Tenders Electronic Daily), Publications Office of the European Union. The values are as the buyer published them. For a framework agreement, the value is a ceiling.